BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 16502484)

  • 21. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility among bacterial isolates from ICU and non-ICU setting and different age groups: results from the tigecycline evaluation and Surveillance trial in North America.
    Low DE; Markovic MJ; Dowzicky MJ
    J Chemother; 2009 Feb; 21(1):16-23. PubMed ID: 19297267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
    Hwang H; Kim B
    Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015.
    Kim D; Ahn JY; Lee CH; Jang SJ; Lee H; Yong D; Jeong SH; Lee K
    Ann Lab Med; 2017 May; 37(3):231-239. PubMed ID: 28224769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
    Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the main MDR pathogens: prevalence and treatment options.
    Esposito S; De Simone G
    Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
    Zhang F; Li Y; Lv Y; Zheng B; Xue F
    J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998.
    Fluit AC; Verhoef J; Schmitz FJ;
    Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):617-25. PubMed ID: 11714042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eight-year trends in the relative isolation frequency and antimicrobial susceptibility among bloodstream isolates from Greek hospitals: data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance - WHONET-Greece, 2010 to 2017.
    Polemis M; Tryfinopoulou K; Giakkoupi P; ; Vatopoulos A
    Euro Surveill; 2020 Aug; 25(34):. PubMed ID: 32856583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.
    Balode A; Punda-Polić V; Dowzicky MJ
    Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antibiotic resistance in US hospitals.
    Edelsberg J; Weycker D; Barron R; Li X; Wu H; Oster G; Badre S; Langeberg WJ; Weber DJ
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):255-62. PubMed ID: 24360267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
    Namdari H; Tan TY; Dowzicky MJ
    Int J Infect Dis; 2012 Jan; 16(1):e60-6. PubMed ID: 22104303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011.
    Lee DS; Choe HS; Lee SJ; Bae WJ; Cho HJ; Yoon BI; Cho YH; Han CH; Jang H; Park SB; Cho WJ; Lee SJ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5384-93. PubMed ID: 23959315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bloodstream infections in southwestern China: 2012 Whire Union report on bacterial susceptibility to antibiotics].
    Huang YC; Xie Y; Chen ZX; Liu B; Fei Y; Du Y; Shan B; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 46(1):75-81. PubMed ID: 25993745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
    Gentry CA; Williams RJ
    Microb Drug Resist; 2015 Dec; 21(6):590-9. PubMed ID: 26207392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.